Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,736 | 28,024 | 31,164 | 34,234 | 27,498 |
| Receivables | 19,896 | 12,120 | 13,643 | 12,127 | 10,209 |
| Inventories | 4,629 | 4,038 | 2,863 | 2,839 | 2,799 |
| TOTAL | $42,585 | $47,259 | $50,210 | $50,998 | $44,443 |
| Non-Current Assets | |||||
| PPE Net | 4,496 | 5,055 | 5,197 | 5,791 | 6,279 |
| Intangibles | 38 | 51 | 64 | 76 | 89 |
| Other Non-Current Assets | 9,410 | 9,628 | 9,822 | 10,010 | 11,112 |
| TOTAL | $13,944 | $14,734 | $15,083 | $15,877 | $17,480 |
| Total Assets | $56,529 | $61,993 | $65,293 | $66,875 | $61,923 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,059 | 10,339 | 13,940 | 13,250 | 10,550 |
| Accrued Expenses | 4,868 | 8,736 | 7,624 | 6,583 | 6,371 |
| Other current liabilities | 1,732 | 1,225 | 1,848 | 1,737 | 1,905 |
| TOTAL | $24,184 | $21,964 | $25,039 | $23,035 | $20,050 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,680 | 51,551 | 32,673 | 34,070 | 34,193 |
| Deferred Revenues | 1,599 | 765 | 767 | 642 | 437 |
| Other Non-Current Liabilities | 63,918 | 63,490 | 60,610 | 57,188 | 54,779 |
| TOTAL | $125,488 | $122,163 | $100,599 | $97,609 | $93,671 |
| Total Liabilities | $149,672 | $144,127 | $125,638 | $120,644 | $113,721 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,913 | 41,468 | 40,164 | 38,886 | 36,592 |
| Common Shares | 41 | 41 | 40 | 39 | 36 |
| Retained earnings | -270,017 | -256,796 | -227,851 | -213,296 | -200,929 |
| TOTAL | $-93,143 | $-82,134 | $-60,345 | $-53,769 | $-51,798 |
| Total Liabilities And Equity | $56,529 | $61,993 | $65,293 | $66,875 | $61,923 |